Abstract / Summary
A systematic review and a study level meta-analysis was conducted to assess the association between the T-786C polymorphism of the nitric oxide synthase 3 (NOS3) gene with acute coronary syndrome (ACS) or premature coronary artery disease (PCAD). Online databases of PubMed, EMBASE, MEDLINE, Scopus, Cochrane library and Web of Science were systematically searched, yielding 23 different studies (from 22 articles, involving 17,324 subjects), which were included for quantitative synthesis. Study level odds ratios (ORs) and their 95% confidence intervals (CI) were pooled using random effects, employing a Z test. Pooled results suggested a significant association between T-786C polymorphism and ACS or PCAD through dominant and allelic genetic model comparisons (OR, 1.26, 95% CI, 1.09-1.45, p = 0.001 and OR, 1.26, 95% CI, 1.11-1.43, p = 0.0002 respectively). Leave-one-out sensitivity analysis, in addition to the results for the myocardial infarction endpoint, attested to the robustness of the obtained results. Large, prospective investigations are, however, warranted to confirm the presented findings.
Topics
Primary Source
Cytokine
Ask Prognia AI
Have questions about this meta-analysis?
Prognia AI can search this source alongside 35M+ PubMed papers and current ESC, AHA, NICE, and ADA guidelines to give you a fully cited clinical answer.
Related Clinical Guidelines
Related Blog Posts
ESC 2023 Heart Failure Guidelines: What Every Cardiologist Needs to Know
The 2023 focused update to the ESC Heart Failure Guidelines introduced key changes to SGLT2 inhibitor recommendations, HFmrEF management, and device therapy thresholds. Here is a practical summary.
CHADS₂-VASc in Practice: When to Start Anticoagulation in AF
A practical walkthrough of the CHADS₂-VASc scoring system, its ESC guideline thresholds, and how to use it alongside HAS-BLED to counsel patients with atrial fibrillation.